MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Trastuzumab deruxtecan

  1. Home
  2. Drugs
  3. Trastuzumab deruxtecan
  4. Clinical Trials

Clinical Trials Related to Trastuzumab deruxtecan

Related studies linked through entity extraction aliases.

NCT03505710

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer

Status
TERMINATED
Phase
PHASE2

NCT03424005

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Status
RECRUITING
Phase
PHASE1/PHASE2

NCT03334617

Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.